AU2001266124A1 - 2-aminothiazoline derivatives and their use as no-synthase inhibitors - Google Patents

2-aminothiazoline derivatives and their use as no-synthase inhibitors

Info

Publication number: AU2001266124A1
Authority: AU; Australia
Prior art keywords: synthase inhibitors; aminothiazoline; derivatives; aminothiazoline derivatives; synthase
Prior art date: 2000-06-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001266124A

Inventor

Eric Bacque

Antony Bigot

Jean-Christophe Carry

Dominique Damour

Claude Guyon

Serge Mignani

Michel Tabart

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aventis Pharma SA

Original Assignee

Aventis Pharma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-09

Filing date

2001-06-07

Publication date

2001-12-17

2001-06-07 Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA

2001-12-17 Publication of AU2001266124A1 publication Critical patent/AU2001266124A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Obesity (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AU2001266124A 2000-06-09 2001-06-07 2-aminothiazoline derivatives and their use as no-synthase inhibitors Abandoned AU2001266124A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0007397A FR2810037B1 (en)	2000-06-09	2000-06-09	USE OF 2-AMINOTHIAZOLINE DERIVATIVES AS INDUCTIBLE NO-SYNTHASE INHIBITORS
FR0007397		2000-06-09
PCT/FR2001/001760 WO2001094325A1 (en)	2000-06-09	2001-06-07	2-aminothiazoline derivatives and their use as no-synthase inhibitors

Publications (1)

Publication Number	Publication Date
AU2001266124A1 true AU2001266124A1 (en)	2001-12-17

Family

ID=8851134

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001266124A Abandoned AU2001266124A1 (en)	2000-06-09	2001-06-07	2-aminothiazoline derivatives and their use as no-synthase inhibitors

Country Status (28)

Country	Link
EP (1)	EP1299365B1 (en)
JP (1)	JP4238026B2 (en)
KR (1)	KR20030025931A (en)
CN (1)	CN1202096C (en)
AP (1)	AP2002002708A0 (en)
AR (1)	AR029937A1 (en)
AT (1)	ATE305460T1 (en)
AU (1)	AU2001266124A1 (en)
BR (1)	BR0111986A (en)
CA (1)	CA2411760C (en)
DE (1)	DE60113689T2 (en)
DK (1)	DK1299365T3 (en)
DZ (1)	DZ3367A1 (en)
EA (1)	EA200300010A1 (en)
EC (1)	ECSP024375A (en)
ES (1)	ES2248347T3 (en)
FR (1)	FR2810037B1 (en)
HR (1)	HRP20020970A2 (en)
HU (1)	HUP0301000A2 (en)
IL (1)	IL153328A0 (en)
MA (1)	MA25814A1 (en)
MX (1)	MXPA02012071A (en)
NO (1)	NO20025884L (en)
NZ (1)	NZ522968A (en)
OA (1)	OA12286A (en)
PL (1)	PL360285A1 (en)
WO (1)	WO2001094325A1 (en)
ZA (1)	ZA200209769B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60140964D1 (en) *	2001-09-26	2010-02-11	Yissum Res Dev Co	Sphingolipiden
RU2004117525A (en) *	2001-11-09	2005-04-20	Авентис Фарма С.А. (Fr)	APPLICATION OF 2-AMINO-4-HETEROARIETHYLTHIAZOLINE DERIVATIVES AS INDUCTIBLE NO-SYNTHASE INHIBITORS
IL161843A0 (en) *	2001-11-09	2005-11-20	Aventis Pharma Sa	Use of 2-amino-4-pyridylmethyl-thiazoline dervatives as inhibitors of inducible no-synthase
ATE319693T1 (en) *	2001-11-09	2006-03-15	Aventis Pharma Sa	2-AMINO-THIAZOLINE DERIVATIVES AND THEIR USE AS INHIBITERS OF INDUCIBLE NO-SYNTHASE
AU2002238889A1 (en) *	2002-03-14	2003-09-22	Dainippon Pharmaceutical Co., Ltd.	Nitrogen monoxide synthase inhibitors
AU2003257300B2 (en)	2002-08-07	2010-01-21	Neuraxon Inc.	Amino benzothiazole compounds with NOS inhibitory activity
DE10332560B4 (en) *	2003-07-11	2010-07-08	Chiracon Gmbh	Process for the preparation of β-heteroaryl-2-alanine compounds via 2-amino-2- (heteroarylmethyl) -carboxylic acid compounds
KR101800507B1 (en)	2015-09-18	2018-01-18	주식회사 이엔이티아이	How to take advantage of the purification plants equipment and self-cleaning screen to clean up pollution by continue flowing sewage and process wastewater into the river

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5066662A (en) *	1990-05-21	1991-11-19	Warner-Lambert Company	Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
SI9300616A (en) *	1992-11-27	1994-06-30	Wellcome Found	Enzyme inhibitors
JPH09504028A (en) *	1993-10-21	1997-04-22	ジー．ディー．サールアンドカンパニー	Amidino derivatives useful as nitric oxide synthase inhibitors
WO1996014842A1 (en) *	1994-11-15	1996-05-23	Merck & Co., Inc.	Substituted heterocycles as inhibitors of nitric oxide synthase
WO2001047931A1 (en) *	1999-12-24	2001-07-05	Kyowa Hakko Kogyo Co., Ltd.	Fused purine derivatives

2000
- 2000-06-09 FR FR0007397A patent/FR2810037B1/en not_active Expired - Fee Related
2001
- 2001-06-07 OA OA1200200372A patent/OA12286A/en unknown
- 2001-06-07 NZ NZ522968A patent/NZ522968A/en unknown
- 2001-06-07 HU HU0301000A patent/HUP0301000A2/en unknown
- 2001-06-07 DE DE60113689T patent/DE60113689T2/en not_active Expired - Lifetime
- 2001-06-07 JP JP2002501875A patent/JP4238026B2/en not_active Expired - Fee Related
- 2001-06-07 BR BR0111986-9A patent/BR0111986A/en not_active Application Discontinuation
- 2001-06-07 AU AU2001266124A patent/AU2001266124A1/en not_active Abandoned
- 2001-06-07 ES ES01943580T patent/ES2248347T3/en not_active Expired - Lifetime
- 2001-06-07 HR HR20020970A patent/HRP20020970A2/en not_active Application Discontinuation
- 2001-06-07 EA EA200300010A patent/EA200300010A1/en unknown
- 2001-06-07 PL PL36028501A patent/PL360285A1/en unknown
- 2001-06-07 AT AT01943580T patent/ATE305460T1/en not_active IP Right Cessation
- 2001-06-07 AR ARP010102730A patent/AR029937A1/en not_active Application Discontinuation
- 2001-06-07 CA CA002411760A patent/CA2411760C/en not_active Expired - Fee Related
- 2001-06-07 DZ DZ013367A patent/DZ3367A1/en active
- 2001-06-07 CN CNB01813386XA patent/CN1202096C/en not_active Expired - Fee Related
- 2001-06-07 AP APAP/P/2002/002708A patent/AP2002002708A0/en unknown
- 2001-06-07 EP EP01943580A patent/EP1299365B1/en not_active Expired - Lifetime
- 2001-06-07 DK DK01943580T patent/DK1299365T3/en active
- 2001-06-07 IL IL15332801A patent/IL153328A0/en unknown
- 2001-06-07 KR KR1020027016766A patent/KR20030025931A/en not_active Withdrawn
- 2001-06-07 WO PCT/FR2001/001760 patent/WO2001094325A1/en not_active Ceased
- 2001-06-07 MX MXPA02012071A patent/MXPA02012071A/en active IP Right Grant
2002
- 2002-12-02 ZA ZA200209769A patent/ZA200209769B/en unknown
- 2002-12-06 NO NO20025884A patent/NO20025884L/en not_active Application Discontinuation
- 2002-12-09 MA MA26939A patent/MA25814A1/en unknown
- 2002-12-09 EC EC2002004375A patent/ECSP024375A/en unknown

Also Published As

Publication number	Publication date
ES2248347T3 (en)	2006-03-16
PL360285A1 (en)	2004-09-06
DZ3367A1 (en)	2001-12-13
ECSP024375A (en)	2003-02-06
CA2411760A1 (en)	2001-12-13
EP1299365A1 (en)	2003-04-09
ZA200209769B (en)	2004-03-02
ATE305460T1 (en)	2005-10-15
NO20025884L (en)	2003-01-29
EA200300010A1 (en)	2003-06-26
JP4238026B2 (en)	2009-03-11
NO20025884D0 (en)	2002-12-06
CA2411760C (en)	2009-12-29
FR2810037B1 (en)	2004-04-23
DK1299365T3 (en)	2006-02-06
EP1299365B1 (en)	2005-09-28
OA12286A (en)	2006-05-12
CN1202096C (en)	2005-05-18
IL153328A0 (en)	2003-07-06
MXPA02012071A (en)	2004-09-10
DE60113689D1 (en)	2006-02-09
FR2810037A1 (en)	2001-12-14
AR029937A1 (en)	2003-07-23
JP2003535853A (en)	2003-12-02
HUP0301000A2 (en)	2003-08-28
KR20030025931A (en)	2003-03-29
DE60113689T2 (en)	2006-07-13
NZ522968A (en)	2005-07-29
HRP20020970A2 (en)	2005-02-28
MA25814A1 (en)	2003-07-01
BR0111986A (en)	2003-04-01
CN1444572A (en)	2003-09-24
HK1057900A1 (en)	2004-04-23
AP2002002708A0 (en)	2002-12-31
WO2001094325A1 (en)	2001-12-13

Publication	Publication Date	Title
AU2001244355A1 (en)	2001-10-15	Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU7392101A (en)	2001-10-23	8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
AU2002226486A1 (en)	2002-07-08	Novel c-glycoside derivatives and use thereof
SI1686119T1 (en)	2009-12-31	Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
AU2001244399A1 (en)	2001-10-23	Gamma-secretase inhibitors
AU2001240542A1 (en)	2001-08-14	Heterocyclic compounds and their use as parp inhibitors
IL153246A0 (en)	2003-07-06	Substituted quinazoline derivatives and their use as inhibitors
AU2001258771A1 (en)	2001-11-26	-secretase inhibitors
PL362917A1 (en)	2004-11-02	New mandelic acid derivatives and their use as throbin inhibitors
AU2002226487A1 (en)	2002-07-08	Novel c-glycoside derivatives and use thereof
HUP0203961A3 (en)	2003-05-28	3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes
AU2002230836A1 (en)	2002-07-01	Benzylamine derivatives and their use as thrombin inhibitors
AU2002216650A1 (en)	2002-05-15	Triazine derivatives as lpaat-b inhibitors and uses thereof
AU2001281799A1 (en)	2001-12-11	Benzamide derivatives and their use as apob-100 and mtp inhibitors
AU2001244596A1 (en)	2001-10-15	Indolylpyrrole derivatives and cell death inhibitors
IL152396A0 (en)	2003-05-29	New thiochromane derivatives derivatives and their use as thrombin inhibitors
AU2001276027A1 (en)	2002-02-05	Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
AU4501199A (en)	1999-12-20	8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU2001277561A1 (en)	2002-03-04	Biphenyl derivatives and the use thereof as integrin inhibitors
AU2001266124A1 (en)	2001-12-17	2-aminothiazoline derivatives and their use as no-synthase inhibitors
AU1039801A (en)	2001-05-08	Compounds and their use as cysteine protease inhibitors
AU4432001A (en)	2001-10-08	Trityl-type compounds and their use
AU2001259626A1 (en)	2001-12-24	Indole derivatives and their use as 15-lipoxygenase inhibitors
AU2001235364A1 (en)	2001-09-03	Tetrahydronaphtalene derivatives and their use
AU2001282268A1 (en)	2002-02-18	Phenantridine derivatives and their use as anti-telomerase agent

Legal Events

Date	Code	Title	Description
2007-01-25	MK4	Application lapsed section 142(2)(d) - no continuation fee paid for the application